142
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Association between metabolic gene polymorphisms and susceptibility to peripheral nerve damage in workers exposed to n-hexane: A preliminary study

, , , , , , , , & show all
Pages 61-69 | Received 10 Aug 2005, Published online: 08 Oct 2008

References

  • Cao DZ, Wan JX, Zhu XM, Liu J, Jin XP, Xia ZL. Effect of GSTM1 and CYP2E1 genetic polymorphism on susceptibility to chronic benzene poisoning. Journal of Labor Medicine 2001; 18: 334–337
  • Chang CM, Yu CW, Fong KY, Leung SY, Tsin TW, Yu YL, Cheung TF, Chan SY. N-hexane neuropathy in offset printers. Journal of Neurology, Neurosurgery and Psychiatry 1993; 56: 538–542
  • Couri D, Abdel-Rahman MS, Hetland LB. Biotransformation of n-hexane and methyl n-butyl ketone in guinea pigs and mice. American Industrial Hygiene Association Journal 1978; 39: 295–300
  • Crosbie SJ, Blain PG, Williams FM. Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers. Human Experimental Toxicology 1997; 16: 131–137
  • Daiker DH, Shipp BK, Schoenfeld HA, Klimpel GR, Witz G, Moslen MT, Ward JB, Jr. Effect of CYP2E1 induction by ethanol on the immunotoxicity and genotoxicity of extended low-level benzene exposure. Journal of Toxicology and Environmental Health 2000; 59: 181–196
  • De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Pittman GS, Bell DA. Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiology Biomarkers and Prevention 2003; 12: 14–22
  • Decaprio AP, Kinney EA, Fowke JH. Regioselective binding of 2,5-hexanedione to high-molecular-weight rat neurofilament protein in vitro. Toxicology and Applied Pharmacology 1997; 145: 211–217
  • Diagnostic criteria of occupational acute neurotoxic disorders caused by chemicals ( GBZ76 2002a). Ministry of Health, Beijing, PR China.
  • Diagnostic criteria of occupational chronic n-hexane poisoning ( GBZ84 2002b). Ministry of Health, Beijing, PR China.
  • Frommer U, Ullrich V, Orrenius S. Influence of inducers and inhibitors on the hydroxylation pattern of N-hexane in rat liver microsomes. FEBS Letters 1974; 41: 14–16
  • Graham DG, Amarnath V, Valentine WM, Pyle SJ. Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Critical Reviews in Toxicology 1995; 25: 91–112
  • Graham DG, Anthony DC, Boeklheide K, Maschmann NA, Richards RG, Wolfram AM, Sham BR. Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking. Toxicology and Applied Pharmacology 1982; 64: 415–422
  • Hayashi SI, Watanabe J, Kawajiri K. Genetic polymorphism of the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. Journal of Biochemistry 1991; 110: 559–565
  • He FS, Ren YJ, Wang SJ. Occupational medicine of China. Publishing Company of Public Health, Beijing 1999; 437–439
  • He JX, Huang XQ, Xie WL, Kong LZ, Zhu GH, Zhang DH, Huang JX. Effect of N-hexane on exposure worker health. Chinese Occupational Medicine 2002b; 29: 32–34, [in Chinese]
  • He JX, Li LY, Huang XQ, Lin BJ, Wu K, Chen GH, Liang N, Huang XC. Survey of occupational damage induced by n-hexane in Shenzhen city. Chinese Occupational Medicine 2000; 27: 50–51, [in Chinese]
  • He JX, Lin BJ, Wu ZJ. Survey of occupational hazards caused by organ solvent in foreign-own enterprise in Shenzhen city. Occupation and Health 2002a; 18: 15–16, [in Chinese]
  • Iba MM, Fung J, Gonzalez FJ. Function Cyp2e1 is required for substantial in vivo formation of 2,5-hexanedione from n-hexane in the mouse. Toxicokinetics and Metabolism 2000; 74: 582–586
  • Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Movement Disorders 1998; 13: 24–34
  • Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H, Weston A, Harris CC. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Research 1992; 52: 6712–6715
  • Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, Ookuma R, Bell DA. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 1996; 17: 1855–1859
  • Koop DR, Tierney DJ. Multiple mechanisms in the regulation of ethanol-inducible cytochrome P450IIE1. Bioessays 1990; 12: 429–435
  • Mannervik B, Awasthi YC, Board PG, Haves JD, Di Ilio C, Ketterer B, Listowsky I, Morgenstern R, Muramatsu M, Pearson WR. Nomenclature for human glutathione transferases. Biochemistry Journal 1992; 282: 305–306
  • McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W. A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicology and Applied Pharmacology 1998; 152: 276–281
  • Medrano CJ, LoPachin RM. Effects of acrylamide and 2,5-hexanedione on brain mitochondrial respiration. Neurotoxicology 1989; 10: 249–255
  • Miller SA, Dykes DD, Polesly HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 1988; 16: 12–15
  • Morohashi K, Sdano H, Okada Y, Omura T. Position specificity in n-hexane hydroxylation by two forms of cytochrome P-450 in rat liver microsomes. Journal of Biochemistry 1983; 93: 413–419
  • Oge AE, Yazici J, Boyaciyan A, Eryildiz A, Ornek I, Konyalioglu R, Cengiz S, Oksak OZ, Asar S, Baslo A. Peripheral and central conduction in n-hexane polyneuropathy. Muscle and Nerve 1994; 17: 1416–1430
  • Pastore C, Izura V, Marhuenda D, Prieto MJ, Roel J, Cardona A. Partial conduction block in n-hexane neuropathy. Muscle and Nerve 2002; 26: 132–135
  • Pyle SJ, Amarnath V, Graham DG, Anthony DC. The role of pyrrole formation in the alteration of neurofilament transport induced during exposure to 2,5-hexanedione. Journal of Neuropathology and Experimental Neurology 1992; 51: 451–458
  • Raunio H, Liira J, Elovaara E, Pelkonen O. Cytochrome P450 isozyme induction by methyl ethyl ketone and m-xylene in rat liver. Toxicology and Applied Pharmacology 1990; 103: 175–179
  • Robertson P, Jr, White EL, Bus JS. Effects of methyl ethyl ketone pretreatment on hepatic mixed-function oxidase activity and on in vivo metabolism of n-hexane. Xenobiotica 1989; 19: 721–729
  • Saarikoski ST, Voho A, Reinikainen M, Anttil S, Karjalainen A, Malaneilie C, Vainio H, Husgafvel-Pursiainen K, Hirvonen A. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. International Journal of Cancer 1998; 77: 516–521
  • Savolainen VT, Pajarinen J, Perola M, Penttila A, Karhunen PJ. Polymorphism in the cytochrome P450 2E1 gene and the risk of alcoholic liver disease. Journal of Hepatology 1997; 26: 55–61
  • Shao P, He JC, Ni PQ, Zheng RY. Display of neuro-electrophysiology in patients with chronic n-hexane intoxication. Zhongguo Shiyong Neike Zazhi 1999; 19: 355–357
  • Spencer PS, Bischoff MC, Schaumburg HH. On the specific molecular configuration of neurotoxic aliphatic hexacarbon compounds causing central–peripheral distal axonpathy. Toxicology and Applied Pharmacology 1978; 44: 17–28
  • Spencer PS, Sabri MI, Moore CL. Does a defect in energy metabolism in the nerve fiber underlie axonal degeneration in polyneuropathies?. Annals in Neurology 1979; 5: 501–507
  • Stephens S, Stephens EA, Taylor JA, Kaplan N, Yang CH, Hsieh LL, Lucier GW, Bell DA. Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics 1994; 4: 185–192
  • Tefre T, Ryberg D, Haugen A, Nebert DW, Skaug V, Brogger A, Borresen AL. Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1991; 1: 20–25
  • Toftgard R, Haaparanta T, Eng T, Halpert J. Rat lung and liver microsomal cytochrome P-450 isozymes involved in the hydroxylation of n-hexane. Biochemistry and Pharmacology 1986; 35: 3733–3738
  • Uematsu F, Ikawa S, Kikuchi H, Sagami I, Kanamaru R, Abe T, Satoh K, Motomiya M, Watanbe M. Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics 1994; 4: 55–63
  • Uematsu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Ohmachi T, Wakui A, Kanamaru R, Watanabe M. Association between restriction fragment length polymorphism of the human cytochrome P450 IIE1 gene and susceptibility to lung cancer. Japan Journal of Cancer Research 1991; 82: 254–256
  • Umeno M, McBride OW, Yang CS, Gelboin HV, Gonzalez FJ. Human ethanol-inducible P450IIE1: complete gene sequence, promoter characterization, chromosome mapping, and cDNA-directed expression. Biochemistry 1988; 27: 9006–9013
  • Vidal F, Lorenzo A, Auget T, Olona M, Broch M, Gutierrez C, Aguilar C, Estupina P, Santos M, Richart C. Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver disease. Journal of Hepatology 2004; 41: 744–750
  • Wang JD, Chang YC, Kao KP, Huang CC, Lin CC, Yeh WY. An outbreak of n-hexane-induced polyneuropathy among press proofing worker. American Journal of Industrial Medicine 1986; 10: 111–118
  • Wang LD, Zheng S, Liu B, Zhu JX, Li YJ, Li JX. CYP1A1, GSTs and mEH polymorphisms and susceptibility to esophageal carcinoma: study of population from a high-incidence area in north China. World Journal of Gastroenterology 2003; 9: 1394–1397
  • Zhai YH, Shi YB, Zhong LJ, Sun L, Sun XW, Cheng JR, Xiang YB, Lim YJ, Dai XD, Shields P, Gao YT. Cytochrome P450 2E1 genetic polymorphism and non-smoking female lung cancer risk. Carcinogenesis Teratogenesis and Mutagenesis 1998; 10: 355–358
  • Zhong S, Wyllie AH, Barnes D, Wolf CR, Spur NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 1993; 14: 1821–1824
  • Zhu M, Spink DC, Yan B, Bank S, DeCaprio AP. Formation and structure of cross-linking and monomeric pyrrole autoxidation products in 2,5-hexanedione-treated amino acids, peptides, and protein. Chemical Research in Toxicology 1994; 7: 551–558

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.